Nova Leap Health Corp.
NLH.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.83% | 526.31% | -191.59% | -52.02% | 149.55% |
| Total Depreciation and Amortization | 32.61% | 1.50% | 5.26% | -7.58% | -20.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.21% | -358.32% | 947.15% | 87.03% | -121.80% |
| Change in Net Operating Assets | -89.25% | 206.59% | -37.99% | 65.35% | 133.55% |
| Cash from Operations | -41.90% | 17.89% | -25.90% | 3.58% | -32.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 26.82% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 28.19% | -- | -- | -- | -- |
| Total Debt Issued | -24.41% | -- | -- | -- | -- |
| Total Debt Repaid | 18.72% | -156.10% | -1.44% | 38.73% | 80.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -247.15% | -- | -- | -- | -- |
| Cash from Financing | -34.30% | 1,254.47% | -1.44% | 38.73% | 80.88% |
| Foreign Exchange rate Adjustments | 101.91% | -15,800.00% | -92.86% | 130.43% | -185.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.75% | -78.63% | 302.47% | -78.11% | 204.72% |